Jan Henrik Finke

Jan Henrik Finke is a Lecturer and Head of the Division for Pharma and Bio Particle Technology at the Institute for Particle Technology (iPAT) within the Faculty of Mechanical Engineering at Braunschweig University of Technology. He also serves as a Senior Scientist at the Fraunhoig Institute for Surface Engineering and Thin Films since 2020, and previously held a part-time Substitute Professorship in Pharmaceutical Technology at Friedrich-Schiller-University Jena during the 2021/22 academic year.

Dr. Finke completed his doctorate in 2014 with research focused on 'Manufacturing colloidal drug delivery systems in customized microsystems: Characterization of process efficiency and interactions.' He studied Pharmacy at the University of Münster from 2002-2006 and has since built an extensive career in pharmaceutical technology and particle engineering.

His research interests span pharmaceutical technology, particle engineering, drug delivery systems, microsystems engineering, and 3D printing of pharmaceuticals. Dr. Finke's work focuses on developing innovative approaches for drug formulation, particularly for poorly water-soluble compounds, and advancing manufacturing processes for pharmaceutical products including probiotic formulations and personalized medicine.

Analysis of his recent publications (2023-2025) reveals a strong focus on pharmaceutical manufacturing challenges, particularly tablet production with living microorganisms, advanced drug delivery systems, and the application of computational modeling to pharmaceutical processes. His work bridges fundamental particle technology with practical pharmaceutical applications, with increasing emphasis on personalized medicine approaches through 3D printing technologies.

Dr. Finke has made significant contributions to understanding the survival of microorganisms during pharmaceutical processing, the development of novel drug delivery systems, and the optimization of manufacturing processes for complex pharmaceutical formulations. His research has practical implications for improving drug bioavailability and developing personalized medication approaches.

As Head of the Pharma and Bio Particle Technology division, Dr. Finke leads research efforts focused on particle-based pharmaceutical technologies, including nanoparticle formulations, solid lipid nanoparticles, and advanced manufacturing techniques for drug delivery systems. His work connects engineering principles with pharmaceutical sciences to address challenges in modern drug development and manufacturing.